Specific premature epigenetic aging of cartilage in osteoarthritis
Use este enlace para citar
http://hdl.handle.net/2183/25238Colecciones
- INIBIC- REUMA - Artigos [184]
Metadatos
Mostrar el registro completo del ítemTítulo
Specific premature epigenetic aging of cartilage in osteoarthritisAutor(es)
Fecha
2016-09-28Cita bibliográfica
Vidal-Bravo L, López Golán Y, Mera-Varela A, Rego-Pérez I, Horvath S, Zhang Y, et al. Specific premature epigenetic aging of cartilage in osteoarthritis. Aging (Albany NY). 2016;8(9): 2222-2230
Resumen
[Abstract] Osteoarthritis (OA) is a disease affecting multiple tissues of the joints in the elderly, but most notably articular cartilage. Premature biological aging has been described in this tissue and in blood cells, suggesting a systemic component of premature aging in the pathogenesis of OA. Here, we have explored epigenetic aging in OA at the local (cartilage and bone) and systemic (blood) levels. Two DNA methylation age-measures (DmAM) were used: the multi-tissue age estimator for cartilage and bone; and a blood-specific biomarker for blood. Differences in DmAM between OA patients and controls showed an accelerated aging of 3.7 years in articular cartilage (95% CI = 1.1 to 6.3, P = 0.008) of OA patients. By contrast, no difference in epigenetic aging was observed in bone (0.04 years; 95% CI = -1.8 to 1.9, P = 0.3) and in blood (-0.6 years; 95% CI = -1.5 to 0.3, P = 0.2) between OA patients and controls. Therefore, premature epigenetic aging according to DNA methylation changes was specific of OA cartilage, adding further evidence and insight on premature aging of cartilage as a component of OA pathogenesis that reflects damage and vulnerability.
Palabras clave
Osteoarthritis
Biological age
Epigenetics
DNA methylation
Telomere length shortening
Biological age
Epigenetics
DNA methylation
Telomere length shortening
Versión del editor
Derechos
Atribución 3.0 España
ISSN
1945-4589